Novo Nordisk A/S
NVODrug Manufacturers - General
$39.14+2.22%As of Oct 29vs prior close
- Market cap
- $172.6B
- P/E (TTM)
- 11.4×
- P/E (FY1)
- 11.7×
- From 52W high
- −35.77%
- EPS (YE25)
- DKK 23.03
- Revenue (YE25)
- DKK 309.1B
- Net margin
- 33.14%
- Dividend yield
- 4.74%
Nomior Score
53
Discounted QualityTop 44% of the scored universe
Growth32
Quality82
Value72
Momentum28
Resilience49
Growth
+16.75%revenue a year over 6 fiscal years
YE19 DKK 122BYE25 DKK 309.1B
Connections
Revenue to profitYE25
33% of revenue became net profit, down 2 pts on a year.
Who owns it
4tracked portfolios